Stock Analyses

Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.

Clear
6,990 stocks · page 55 of 117
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
INBKZ
First Internet Bancorp
Undervalued
Financial Services
Price$25.32
Model IV$30.41
P/IV0.83
Discount 17% Return to IV: +20.1%
INBS
INTELLIGENT BIO SOLUTIONS INC.
Deeply overvalued
Healthcare
Price$2.13
Model IV$0.66
P/IV3.89
Premium +223% Return to IV: -69.0%
Market implies +9.1%/yr vs model +11.4% · in line
INBX
Inhibrx Biosciences, Inc.
Valuation N/A
Healthcare
Price$105.61
Model IV
P/IV
Market implies +150.0%/yr vs model +2.0% · above model
INCR
Intercure Ltd.
Valuation N/A
Healthcare
Price$5.16
Model IV
P/IV
INCY
INCYTE CORP
Undervalued
Industrials
Price$125.31
Model IV$168.99
P/IV0.57
Discount 26% Return to IV: +34.9%
Market implies +7.3%/yr vs model +14.5% · below model
INDB
INDEPENDENT BANK CORP
Deeply overvalued
Financial Services
Price$82.74
Model IV$62.38
P/IV1.27
Premium +33% Return to IV: -24.6%
INDI
indie Semiconductor, Inc.
Fairly valued
Technology
Price$3.08
Model IV$3.35
P/IV1.49
Discount 8% Return to IV: +8.7%
Market implies +5.0%/yr vs model +45.6% · below model
INDO
Indonesia Energy Corp Ltd
Valuation N/A
Energy
Price$3.15
Model IV
P/IV
Market implies +39.1%/yr vs model +0.0% · above model
INDP
Indaptus Therapeutics, Inc.
Valuation N/A
Healthcare
Price$3.14
Model IV
P/IV
INDV
Indivior Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$34.49
Model IV
P/IV
Market implies -5.4%/yr vs model +15.0% · below model
INEO
INNEOVA Holdings Ltd
Deeply undervalued
Industrials
Price$0.55
Model IV$1.99
P/IV0.28
Discount 72% Return to IV: +260.4%
Owner yield 40.5% 10-yr IRR 52.6% · steady
Market implies -19.5%/yr vs model +4.8% · below model
INFQ
Infleqtion, Inc.
Valuation N/A
Technology
Price$13.12
Model IV
P/IV
INFU
InfuSystem Holdings, Inc
Fairly valued
Healthcare
Price$12.15
Model IV$10.28
P/IV0.88
Premium +18% Return to IV: -15.4%
Owner yield 7.0% 10-yr IRR 16.2% · moderate
Market implies +8.6%/yr vs model +10.3% · in line
INFY
Infosys Ltd
Valuation N/A
Technology
Price$11.07
Model IV
P/IV
ING
ING GROEP NV
Valuation N/A
Financial Services
Price$36.96
Model IV
P/IV
INGM
Ingram Micro Holding Corp
Undervalued
Industrials
Price$27.55
Model IV$36.09
P/IV0.78
Discount 24% Return to IV: +31.0%
Market implies -1.4%/yr vs model +3.0% · below model
INGN
Inogen Inc
Deeply undervalued
Healthcare
Price$5.31
Model IV$9.60
P/IV0.68
Discount 45% Return to IV: +80.7%
Market implies -12.7%/yr vs model +2.0% · below model
INGR
Ingredion Inc
Deeply undervalued
Consumer Defensive
Price$100.49
Model IV$209.60
P/IV0.48
Discount 52% Return to IV: +108.6%
Owner yield 12.2% 10-yr IRR 20.3% · steady
Market implies -5.3%/yr vs model +4.0% · below model
INHD
INNO HOLDINGS INC.
Valuation N/A
Basic Materials
Price$3.96
Model IV
P/IV
Market implies +42.4%/yr vs model +0.0% · above model
INKT
MiNK Therapeutics, Inc.
Valuation N/A
Healthcare
Price$12.00
Model IV
P/IV
INLF
INLIF Ltd
Deeply undervalued
Industrials
Price$2.96
Model IV$5.27
P/IV0.72
Discount 44% Return to IV: +77.9%
Market implies -18.5%/yr vs model +40.4% · below model
INLX
INTELLINETICS, INC.
Deeply undervalued
Technology
Price$5.50
Model IV$12.61
P/IV0.50
Discount 56% Return to IV: +129.2%
Market implies -22.8%/yr vs model +9.7% · below model
INM
InMed Pharmaceuticals Inc.
Deeply undervalued
Healthcare
Price$1.30
Model IV$11.60
P/IV0.14
Discount 89% Return to IV: +791.9%
Market implies -49.8%/yr vs model +26.9% · below model
INMB
Inmune Bio, Inc.
Valuation N/A
Healthcare
Price$2.22
Model IV
P/IV
Market implies +123.8%/yr vs model +2.0% · above model
INMD
InMode Ltd.
Deeply undervalued
Healthcare
Price$14.89
Model IV$21.34
P/IV0.65
Discount 30% Return to IV: +43.3%
Owner yield 13.4% 10-yr IRR 25.5% · moderate
Market implies +0.5%/yr vs model +7.6% · below model
INN
Summit Hotel Properties, Inc.
Fairly valued
Financial Services
Price$5.59
Model IV$5.29
P/IV1.09
Premium +6% Return to IV: -5.3%
INNV
InnovAge Holding Corp.
Deeply overvalued
Healthcare
Price$10.75
Model IV$2.09
P/IV3.63
Premium +414% Return to IV: -80.5%
Market implies +28.8%/yr vs model +8.3% · above model
INO
INOVIO PHARMACEUTICALS, INC.
Valuation N/A
Healthcare
Price$1.25
Model IV
P/IV
Market implies +101.8%/yr vs model +2.0% · above model
INOD
INNODATA INC
Deeply overvalued
Technology
Price$53.21
Model IV$30.22
P/IV3.47
Premium +76% Return to IV: -43.2%
Market implies +15.7%/yr vs model +37.8% · below model
INR
INFINITY NATURAL RESOURCES, INC.
Deeply undervalued
Energy
Price$14.92
Model IV$59.30
P/IV0.23
Discount 75% Return to IV: +297.4%
Market implies -12.4%/yr vs model +8.0% · below model
INSE
Inspired Entertainment, Inc.
Overvalued
Technology
Price$5.10
Model IV$4.32
P/IV1.78
Premium +18% Return to IV: -15.3%
Owner yield 12.1% 10-yr IRR 26.3% · moderate
Market implies +8.8%/yr vs model +10.8% · in line
INSG
INSEEGO CORP.
Deeply overvalued
Technology
Price$4.47
Model IV$7.80
P/IV1.68
Discount 43% Return to IV: +74.6%
Market implies -5.6%/yr vs model +2.0% · below model
INSM
INSMED Inc
Deeply overvalued
Healthcare
Price$119.92
Model IV$23.52
P/IV4.55
Premium +410% Return to IV: -80.4%
Market implies +13.6%/yr vs model +33.9% · below model
INSP
Inspire Medical Systems, Inc.
Deeply undervalued
Healthcare
Price$73.00
Model IV$180.13
P/IV0.23
Discount 59% Return to IV: +146.8%
Market implies -16.3%/yr vs model +40.6% · below model
INSW
International Seaways, Inc.
Deeply undervalued
Industrials
Price$103.65
Model IV$529.26
P/IV0.15
Discount 80% Return to IV: +410.6%
Owner yield 9.7% 10-yr IRR 25.9% · grower
Market implies -2.4%/yr vs model +24.6% · below model
INTA
Intapp, Inc.
Deeply overvalued
Technology
Price$37.49
Model IV$15.02
P/IV1.54
Premium +150% Return to IV: -59.9%
Market implies +27.0%/yr vs model +20.3% · above model
INTC
INTEL CORP
Valuation N/A
Technology
Price$108.60
Model IV
P/IV
Market implies +43.5%/yr vs model +0.0% · above model
INTG
INTERGROUP CORP
Deeply overvalued
Real Estate
Price$37.74
Model IV$20.31
P/IV1.91
Premium +86% Return to IV: -46.2%
INTJ
Intelligent Group Ltd
Deeply overvalued
Industrials
Price$3.00
Model IV$3.51
P/IV2.71
Discount 15% Return to IV: +17.0%
Market implies -13.4%/yr vs model +15.0% · below model
INTR
Inter & Co, Inc.
Valuation N/A
Financial Services
Price$5.71
Model IV
P/IV
INTS
INTENSITY THERAPEUTICS, INC.
Valuation N/A
Healthcare
Price$3.98
Model IV
P/IV
INTT
INTEST CORP
Deeply overvalued
Healthcare
Price$11.42
Model IV$4.63
P/IV3.64
Premium +147% Return to IV: -59.4%
Owner yield 5.5% 10-yr IRR 11.3% · moderate
Market implies +17.1%/yr vs model +8.3% · above model
INTU
INTUIT INC.
Deeply undervalued
Technology
Price$303.19
Model IV$713.19
P/IV0.44
Discount 57% Return to IV: +135.2%
Owner yield 5.4% 10-yr IRR 14.8% · grower
Market implies -0.5%/yr vs model +13.4% · below model
INTZ
INTRUSION INC
Valuation N/A
Technology
Price$0.89
Model IV
P/IV
Market implies +41.8%/yr vs model +2.0% · above model
INUV
Inuvo, Inc.
Deeply undervalued
Technology
Price$0.62
Model IV$5.53
P/IV0.29
Discount 89% Return to IV: +793.5%
Market implies -48.4%/yr vs model +9.6% · below model
INV
Innventure, Inc.
Valuation N/A
Financial Services
Price$0.94
Model IV
P/IV
Market implies +49.2%/yr vs model +50.0% · in line
INVA
Innoviva, Inc.
Deeply undervalued
Healthcare
Price$20.66
Model IV$64.08
P/IV0.33
Discount 68% Return to IV: +210.2%
Owner yield 10.0% 10-yr IRR 19.0% · moderate
Market implies -9.4%/yr vs model +6.5% · below model
INVE
Identiv, Inc.
Deeply overvalued
Technology
Price$2.58
Model IV$0.87
P/IV4.73
Premium +198% Return to IV: -66.4%
Market implies +10.8%/yr vs model +2.0% · above model
INVH
Invitation Homes Inc.
Deeply undervalued
Real Estate
Price$26.91
Model IV$57.71
P/IV0.51
Discount 53% Return to IV: +114.5%
Market implies -3.7%/yr vs model +6.9% · below model
INVX
Innovex International, Inc.
Deeply undervalued
Industrials
Price$29.08
Model IV$118.71
P/IV0.23
Discount 76% Return to IV: +308.2%
Owner yield 5.4% 10-yr IRR 16.2% · grower
Market implies -1.5%/yr vs model +24.2% · below model
INVZ
Innoviz Technologies Ltd.
Valuation N/A
Consumer Cyclical
Price$0.30
Model IV
P/IV
Market implies +23.4%/yr vs model +8.0% · above model
IONQ
IonQ, Inc.
Valuation N/A
Technology
Price$36.75
Model IV
P/IV
Market implies +55.1%/yr vs model +50.0% · above model
IONR
ioneer Ltd
Valuation N/A
Basic Materials
Price$2.79
Model IV
P/IV
IONS
IONIS PHARMACEUTICALS INC
Valuation N/A
Healthcare
Price$54.21
Model IV
P/IV
Market implies +9.6%/yr vs model +3.9% · above model
IOR
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/
Deeply overvalued
Financial Services
Price$18.50
Model IV$8.94
P/IV2.01
Premium +107% Return to IV: -51.7%
IOSP
INNOSPEC INC.
Fairly valued
Basic Materials
Price$93.23
Model IV$75.22
P/IV1.10
Premium +24% Return to IV: -19.3%
Market implies +6.8%/yr vs model +4.7% · in line
IOT
Samsara Inc.
Deeply overvalued
Technology
Price$41.65
Model IV$19.32
P/IV1.81
Premium +116% Return to IV: -53.6%
Market implies +10.8%/yr vs model +39.4% · below model
IOTR
iOThree Ltd
Undervalued
Communication Services
Price$2.02
Model IV$2.57
P/IV1.52
Discount 21% Return to IV: +27.1%
Market implies -2.5%/yr vs model +50.0% · below model
IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Valuation N/A
Healthcare
Price$8.60
Model IV
P/IV
Market implies -50.0%/yr vs model +15.0% · below model
IP
INTERNATIONAL PAPER CO /NEW/
Deeply overvalued
Basic Materials
Price$34.53
Model IV$25.01
P/IV1.34
Premium +38% Return to IV: -27.6%
Owner yield 2.5% 10-yr IRR -1.5% · steady
Market implies +8.8%/yr vs model +5.1% · above model